期刊文献+

人端粒酶逆转录酶启动子调控的重组腺病毒的构建及其在膀胱癌细胞中的表达 被引量:5

Construction of an adenovirus vector driven by human telomerase reserve transcriptase gene promoter and Its expression in bladder carcimona
原文传递
导出
摘要 目的构建人端粒酶逆转录酶(hTERT)启动子调控的表达增强型绿色荧光蛋白(EGFP)的腺病毒系统,观察其在膀胱癌细胞中的表达。方法构建带有hTERT启动子的腺病毒穿梭载体pDC315-Tp-EGFP,细胞重组技术获得腺病毒Ad-hTERT-EGFP,按感染复数(MOI)100体外转染膀胱癌细胞株253J及人胚肺成纤维细胞株MRC-5,通过倒置荧光显微镜和RT-PCR分别检测EGFP的表达。带有小鼠巨细胞病毒(mCMV)启动子的腺病毒Ad-EGFP作为阳性对照。结果成功构建出重组腺病毒Ad-hTERT-EGFP,滴度为3.8×10^(10)空斑形成单位(pfu)/ml,Ad-hTERT-EG- FP感染的253J细胞中,(85.2±3.3)%发出明亮的绿色荧光;而其感染的MRC-5细胞未产生绿色荧光(P<0.01);对照病毒Ad-EGFP在253J和MRC-5中分别有(87.1±2.2)%及(92.5±3.1)%的细胞可见到绿色荧光。RT-PCR检测显示:253J细胞转染Ad-hTERT-EGFP、Ad-EGFP后及MRC-5细胞转染Ad-EGFP后均有EGFP基因表达;而MRC-5细胞转染Ad-hTERT-EGFP后未见EGFP基因表达。结论该腺病毒系统中hTERT启动子调控下游基因可选择性地在膀胱肿瘤细胞中表达,在正常细胞中不表达,具有明显的靶向性。 Objective To construct an EGFP labeled recombinant adenovirus vector driven by human telomerase reserve transcriptase (hTERT) promoter and study its expression in bladder carcinoma cell line 253J. Methods The shuttle plasmid pDC315-Tp-EGFP which contained the hTERT promoter was generated. By using AdEasy system,the replication-defective adenovirus Ad-hTERT-EGFP was assem- bled. Bladder cancer cell line 253J and human lung fibroblast cell line MRC-5 were transfected by the recombinant adenovirus of 100 multiplicities of infection (MOI). RT-PCR and fluorescence microscopy were used to detect the mRNA and protein expression, respectively. The recombinant adenovirus Ad-EGFP with mCMV promoter served as positive controls. Results The Ad-hTERT-EGFP was generated successfully and its titer was 3.8 × 10^10 pfu/mL. The EGFP protein was highly expressed in ( 85.2 ± 3.3) % 253J cells which were transfected with Ad-hTERT-EGFP,but not in MRC-5 (P 〈 0.01 ). While transfected with the Ad-EGFP,they expressed the EGFP protein in ( 87.1 ± 2.2 ) % 253J and ( 92.5 -+ 3.1 ) % MRC-5 ceils respectively ( P 〈0.01 ). By RT-PCR ,EGFP mRNA could be detected in both cell lines transfected by Ad- EGFP and 253J cells transfected by Ad-hTERT-EGFP, but couldn't be detected in MRC-5 cells transfected by Ad-hTERT-EGFP. Coaclnsion The downstream gene controlled by hTERT promoter in adenovirus system can be expressed selectively in bladder carcinoma cell line 253J, which showed the obvious targeting character.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2007年第7期850-852,共3页 Chinese Journal of Experimental Surgery
基金 河北省卫生厅青年基金(05119)
关键词 腺病毒载体 膀胱癌 基因治疗 Adenovirus vector Bladder carcinoma Gene therapy
  • 相关文献

参考文献3

  • 1Kraemer K, Fuessel S, Schmidt U, et al. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res,2003,9:3794-3800.
  • 2Natarajan S, Chen Z, Wancewicz EV, et al. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides, 2004,14:263- 273.
  • 3聂明明,方国恩,王星华,苏长青,崔贞福,李林芳,钱其军.基因-病毒治疗系统CNHK300-murine endostatin的构建及体外研究[J].中华实验外科杂志,2006,23(1):45-48. 被引量:12

二级参考文献10

  • 1Wirth T, Zender L, Sehulte B, et al. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res, 2003, 63:3181-3188.
  • 2Qian Q, Sham J, Che X, et al. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously. Chin Med J(Engl), 2002, 115:1213-1217.
  • 3Cao YH. Antiangiogenic gene therapy. Gene Therapy Regulation,2000, 1:123-139.
  • 4Smith ER, Chiocca EA. Oncolytic viruses as novel anticancer agents:turning one scourage against another. Exp Opin Invest Drugs, 2000, 9:311-327.
  • 5Rodriguez R, Schuur ER, Lira HY, et al. Prostate attenuated replication competent adenovirus (ARCA)CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res,1997, 57:2559-2563.
  • 6Ohashi M, Kanai F, Tateishi K, et al. Target gene therapy for α-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. Biochem Biophys Res Commun, 2001,282: 529-535.
  • 7Chen L, Chen D, Manome Y, et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1promoter.J Clin Invest, 1995, 96:2775-2785.
  • 8Shay JW, Baccherti S. A survey of telomerase activity in human cancer.Eur J Cancer, 1997, 33:787-791.
  • 9Shay JW, Wright WE. Telomeres and telomerase: implication for cancer and aging. Radiation Research, 2001, 155: 188-193.
  • 10Gu J, Andreef M, Roth JA, et al. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gene Ther, 2002, 9:30-37.

共引文献11

同被引文献27

  • 1侯建全,温端改,郑志涛,严春寅,郭震华.腺病毒介导的HSV-tk基因治疗膀胱癌的研究[J].中华实验外科杂志,2004,21(7):866-868. 被引量:6
  • 2王亚轩,蔡文清,黎玮,张勇,白志杰,吴建辉.人端粒酶逆转录酶启动子调控腺病毒介导的胸苷激酶基因治疗膀胱癌的实验研究[J].中华泌尿外科杂志,2005,26(4):229-232. 被引量:14
  • 3邢毅飞,肖亚军,曾甫清,张齐钧,肖传国,熊平,冯玮.单纯疱疹病毒胸苷激酶/更昔洛韦系统联合化疗药物治疗前列腺癌[J].中华实验外科杂志,2005,22(11):1367-1368. 被引量:2
  • 4Surowiak P, Pudelko M, Maciejczyk A, et al. The relationship of the expression of proliferetron-related antigens Ki-67 and PCNA in the cells of ductal breast cancer with the differentiation grade. Ginekol Pol, 2005,76:9-14.
  • 5Stefani AL, Barzon L, Castagliuolo I, et al. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol,2005 ,42 :728-735.
  • 6Moriuchi S, Glorioso JC, Maruno M, et al. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase. Cancer Gene Ther,2005 ,12 :487-496.
  • 7Gadal F, Bastias J, Wei MX, et al. " Suicide" gene therapy of breast cancer cells is only cytostatic in vitro but antl-tumoral in vivo on breast MCF7-ras tumor. In Vivo,2004,18:813-818.
  • 8Moatta AM,Tenhunen A, Pasanen T,et al. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. Int J Oncol,2004,24:943-949.
  • 9Hayashi K,Lee JB,Maitani Y,et al. The role cf a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. J Gene Med,2006,8 : 1056-1067.
  • 10Hayshi K, Hayashi T. Seopaduleiol is an inhibitor of herpes simplex virus type 1 and a potentiator of acyclovir. Antiviral Chem Chemother, 1996,7:79-85.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部